Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal. Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions,...
Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal. Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions,...
You must be a Standard 1 Year member to access this content.